Pharma, biopharma, and medical device makers should watch out for these perennial problems, which include inadequate ...
The US Food and Drug Administration (FDA) recently issued its draft guidance, Considerations for the Use of Artificial Intelligence to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback